USPTO trademark

INFUDOPA

RegisteredUSPTOWord markClass 5

"INFUDOPA" is a word mark owned by Dizlin Pharmaceuticals AB, filed at the USPTO on March 6, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Dizlin Pharmaceuticals AB portfolio Get this data via the API

Data current as of October 28, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since October 28, 2025
Filed: March 6, 2025
Registered: October 28, 2025
Expires: Not recorded
Application no.: 99070528
Registration no.: 8003762
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns INFUDOPA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Dizlin Pharmaceuticals AB

Göteborg, Sweden

12 trademarks in the portfolioView company

Representative

Stacey R. Halpern

Knobbe, Martens, Olson & Bear LLP

Goods and services

What the mark covers

The products and services INFUDOPA is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations for treating diseases of the central nervous system

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 28, 2025Notice of registration confirmation emailed
October 28, 2025Registered-principal register
September 9, 2025Official gazette publication confirmation e-mailed
September 9, 2025Published for opposition
September 3, 2025Notification of notice of publication e-mailed
August 11, 2025Approved for pub - principal register
August 7, 2025Assigned to examiner
April 1, 2025Preliminary/voluntary amendment - entered
March 28, 2025Assigned to lie
March 11, 2025Teas voluntary amendment received

3 earlier steps on the official record.

FAQ

About INFUDOPA

Who owns the trademark "INFUDOPA"?

The USPTO trademark "INFUDOPA" (application 99070528) is owned by Dizlin Pharmaceuticals AB.

What is the status of "INFUDOPA"?

Its status at the USPTO is: registered.

When was "INFUDOPA" registered?

It was registered on October 28, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull INFUDOPA and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2a85-4d71-725e-8e7f-09dcee5eaa00
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2a85-4d71-725e-8e7f-09dcee5eaa00",
  "object": "trademark",
  "mark_text": "INFUDOPA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99070528",
  "filing_date": "2025-03-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Dizlin Pharmaceuticals AB",
      "entity_id": "ent_019eb714-5e7f-74dc-8284-fb41228f969a"
    }
  ]
}